CNS Oncology
Volume 11, 2022 - Issue 3
Open access
2,010
Views
0
CrossRef citations to date
0
Altmetric
Case Series
First clinical experience with belzutifan in von Hippel–Lindau disease associated CNS hemangioblastoma
Andrew Dhawan1 Neurological Institute, Cleveland Clinic,Cleveland, OH44195, USACorrespondence[email protected]
https://orcid.org/0000-0002-5027-1277
David M Peereboom2 Taussig Cancer Institute, Cleveland Clinic,Cleveland, OH44195, USA
& Glen HJ Stevens1 Neurological Institute, Cleveland Clinic,Cleveland, OH44195, USA;2 Taussig Cancer Institute, Cleveland Clinic,Cleveland, OH44195, USA
Article: CNS91
|
Received 19 Mar 2022, Accepted 17 Jun 2022, Published online: 12 Jul 2022
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.